1. Search Result
Search Result
Results for "

Am or olfine-hydrochl or ide

" in MedChemExpress (MCE) Product Catalog:

23

Inhibitors & Agonists

1

Biochemical Assay Reagents

1

Inhibitory Antibodies

2

Natural
Products

1

Recombinant Proteins

1

Antibodies

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-101569
    Darovasertib
    4 Publications Verification

    LXS196; ide196

    PKC Cancer
    Darovasertib (LXS196) is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. Darovasertib has the potential for uveal melanoma research .
    Darovasertib
  • HY-169422

    ide275

    DNA/RNA Synthesis Cancer
    GSK4418959 (IDE275) is a selective, reversible and orally active WRN helicase inhibitor. GSK4418959 shows >10,000-fold selectivity over other helicases. GSK4418959 inhibits ATPase and DNA unwinding functions in an ATP-competitive manner. GSK4418959 can be used for the study of microsatellite instability-high (MSI-H) cancer, such as colorectal cancer (CRC) and endometrial cancer (EC) .
    GSK4418959
  • HY-100533
    IDE1
    1 Publications Verification

    Organoid Inflammation/Immunology
    IDE1 is an inducer of definitive endoderm 1.
    IDE1
  • HY-117878
    ML345
    1 Publications Verification

    IDE NOD-like Receptor (NLR) Interleukin Related Inflammation/Immunology Endocrinology
    ML345 is a potent and selective inhibitor of insulin-degrading enzyme (IDE) and NLRP3, with an IC50 of 188 nM against IDE. ML345 targets the Cys819 residue of IDE to inhibit IDE. ML345 selectively binds to NLRP3 in a non-covalent manner. ML345 inhibits inflammatory cytokines (IL-1β, IL-6) and exhibits potent anti-inflammatory activity. ML345 exerts a protective effect against miscarriage .
    ML345
  • HY-N7135

    Tyrosinase Fungal Metabolic Disease Inflammation/Immunology Cancer
    Tropolone is a seven-membered non-benzenoid aromatic compound, which is the precursor of many Azulene derivatives. Tropolone is a potent mushroom tyrosinase inhibitor with an IC50 value of 0.4 μM. Its inhibitory effect can be achieved by dialysis or excess CU2+ Reversa. Tropolone exhibits broad anti-viral and anti-fungal activity and is synergistic upon co-treatment with nucleos(t)ide analog drugs. Tropolone is a promising candidate for research in osteosarcoma .
    Tropolone
  • HY-110197
    6bK TFA
    2 Publications Verification

    IDE Metabolic Disease
    6bK TFA is a selective insulin-degrading enzyme (IDE) inhibitor with an IC50 of 50 nM. 6bK TFA binds to the distal pocket of IDE, thereby blocking substrate binding, peptide unfolding and cleavage processes, and reducing the degradation of insulin, glucagon and amylin. 6bK TFA improves oral glucose tolerance but impairs intraperitoneal glucose tolerance. 6bK TFA can be used in research related to type 2 diabetes .
    6bK TFA
  • HY-100534

    Organoid TGF-beta/Smad Others
    IDE2 is a small molecule cell-permeable inducer of definitive endoderm formation in mouse and human embryonic stem cells (ESCs) by activating the TGF-βsignaling pathway .
    IDE 2
  • HY-W157689
    IDE-IN-2
    1 Publications Verification

    Proteolytic Enzyme IDE Infection Metabolic Disease Cancer
    IDE-IN-2 (Compound 4) is an inhibitor for insulin-degrading enzyme. IDE-IN-2 is predicted to have CYP3A4, CYP2C19, hERG, NADP+, HIF1α and histidine kinase inhibitory activities, and has potential biological activity in anti-diabetic, anti-tumor, anti-bacterial aspects, according to the in silico prediction .
    IDE-IN-2
  • HY-169422A

    ide275 (enantiomer)

    DNA/RNA Synthesis Cancer
    GSK4418959 enantiomer is an enantiomer of GSK4418959 (HY-169422). GSK4418959 (IDE275) is a non-covalent, reversible, selective and orally active WRN helicase inhibitor. GSK4418959 inhibits ATPase and DNA unwinding functions in an ATP-competitive manner. GSK4418959 can be used for the study of microsatellite instability-high (MSI-H) cancer .
    GSK4418959 (enantiomer)
  • HY-143401

    IDE Metabolic Disease
    Hit 1 is an activator of ansulin degrading enzyme (IDE), with an EC50 of 5.5 μM. Hit 1 can decrease glucose-stimulating insulin secretion .
    Hit 1
  • HY-12655

    MMP Metabolic Disease
    IDE-IN-1 (compound 6bK) is an insulin-degrading enzyme (IDE) inhibitor with IC50 value of 50 nM. IDE-IN-1 can be used to study type 2 diabetes .
    IDE-IN-1
  • HY-114611

    IRE1 Metabolic Disease
    BDM44768 is an inhibitior of IDE. BDM44768 exacerbates ER stress-induced IRE1 activation and promotes lipid accumulation in hepatocytes. BDM44768 potentiates activation of the IRE1 pathway in the liver and exacerbates liver lipid accumulation in an acute mice model of ER stress .
    BDM44768
  • HY-N7135R

    Tyrosinase Reference Standards Fungal Metabolic Disease Inflammation/Immunology Cancer
    Tropolone is a seven-membered non-benzenoid aromatic compound, which is the precursor of many Azulene derivatives. Tropolone is a potent mushroom tyrosinase inhibitor with an IC50 value of 0.4 μM. Its inhibitory effect can be achieved by dialysis or excess CU2+ Reversa. Tropolone exhibits broad anti-viral and anti-fungal activity and is synergistic upon co-treatment with nucleos(t)ide analog drugs. Tropolone is a promising candidate for research in osteosarcoma .
    Tropolone (Standard)
  • HY-W616806

    Biochemical Assay Reagents Others
    Sodium 6-oxo-3,6-dihydropurin-7-ide, a purine derivative, is a potential free radical generator and could be used as an indicator of hypoxia.
    Sodium 6-oxo-3,6-dihydropurin-7-ide
  • HY-RS06526

    Small Interfering RNA (siRNA) Others

    IDE Human Pre-designed siRNA Set A contains three designed siRNAs for IDE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    IDE Human Pre-designed siRNA Set A
    IDE Human Pre-designed siRNA Set A
  • HY-RS16920

    Small Interfering RNA (siRNA) Others

    Ide Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ide gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ide Mouse Pre-designed siRNA Set A
    Ide Mouse Pre-designed siRNA Set A
  • HY-W103371R

    o-Sulfobenzimide sodium salt dihydrate (Standard)

    Reference Standards
    Sodium 3-oxo-3H-benzo[d]isothiazol-2-ide 1,1-dioxide dihydrate (Standard) is the analytical standard of Sodium 3-oxo-3H-benzo[d]isothiazol-2-ide 1,1-dioxide dihydrate. This product is intended for research and analytical applications.
    Sodium 3-oxo-3H-benzo[d]isothiazol-2-ide 1,1-dioxide dihydrate (Standard)
  • HY-100533R

    Organoid Reference Standards Inflammation/Immunology
    IDE1 (Standard) is the analytical standard of IDE1 (HY-100533). This product is intended for research and analytical applications. IDE1 is an inducer of definitive endoderm 1.
    IDE1 (Standard)
  • HY-RS23363

    Small Interfering RNA (siRNA) Others

    Ide Rat Pre-designed siRNA Set A contains three designed siRNAs for Ide gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ide Rat Pre-designed siRNA Set A
    Ide Rat Pre-designed siRNA Set A
  • HY-182280

    Insulin Receptor Metabolic Disease
    BDM71230 is an orally active inducer of insulin-degrading enzyme (IDE), with an EC50 of 1.9 μM against human IDE. BDM71230 binds to the interface of IDE dimers and enhances the catalytic activity of IDE via steric effects. BDM71230 can potentiate the hydrolytic effect of IDE on insulin and slightly attenuate the hypoglycemic effect of insulin. BDM71230 serves as a pharmacological tool for investigating IDE function and is applicable to studies related to glucose intolerance .
    BDM71230
  • HY-W038421

    1,3-Dimesityl-1H-imidazol-3-ium-2-ide

    MOFs Others
    1,3-Bis(2,4,6-trimethylphenyl)-1,3-dihydro-2H-imidazol-2-ylidene (1,3-Dimesityl-1H-imidazol-3-ium-2-ide) is a metal-organic framework (MOF).
    1,3-Bis(2,4,6-trimethylphenyl)-1,3-dihydro-2H-imidazol-2-ylidene
  • HY-110197A

    IDE Metabolic Disease
    6bK formate is a potent and selective insulin degrading enzyme (IDE) inhibitor with an IC50 value of 50 nM. 6bK formate increases circulating insulin in high-fat-fed mice. Acute administration of 6bK formate enhances glucose tolerance to oral glucose, notably to a greater extent in high-fat-fed mice. 6bK formate can be used for type 2 diabetes research .
    6bK formate
  • HY-P992056

    Autophagy Cancer
    Anti-Human/Mouse LY6E Antibody (9B12) is a high-affinity, multi-target antibody that binds specifically to LY6E. Anti-Human/Mouse LY6E Antibody (9B12) binds specifically to cell-surface LY6E and enters lysosomes via lipid raft-dependent endocytosis, thereby effectively inhibiting the growth of various LY6E-expressing solid tumors (such as breast cancer and lung cancer) in both in vitro and in vivo models. Anti-Human/Mouse LY6E Antibody (9B12) exerts a dual mechanism of action: on one hand, it blocks the interaction between PILRα and CD8α, specifically reduces the survival rate of peripheral CD8 + T cells and induces their activation, breaking the state of cellular quiescence; on the other hand, it recognizes and immunoprecipitates IDE under both non-denaturing and denaturing conditions, which is applicable to studies on the subcellular localization and protein interactions of IDE. The regulatory effect of Anti-Human/Mouse LY6E Antibody (9B12) on CD8 + T cells strictly depends on the presence of PILRα, and it does not affect CD4 + T cells or T cell development in the thymus, exhibiting high specificity .
    Anti-Human/Mouse LY6E Antibody (9B12)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: